European Journal of Pediatrics

, Volume 124, Issue 2, pp 121–128 | Cite as

Nephrotic syndrome of childhood and disorder of T cell function

  • H. Schulte-Wissermann
  • E.-M. Lemmel
  • M. Reitz
  • J. Beck
  • E. Straub
Article

Abstract

In thirty-two patients with nephrotic syndrome (NS) phytohemagglutinin (PHA)-induced lymphocyte proliferation was studied at various stages of the disease. We demonstrated that lymphocyte transformation during acute exacerbation is markedly decreased, especially if cells are cultured in patient serum. During treatment with steroids PHA-stimulation improves. During full remission all patients showed their maximal lymphocyte stimulation. On the basis of these results and reports from the literature we postulate that patients with the NS have a T cell clone which inhibits the transformation capacity of the remaining lymphocytes through production of a heat stable serum factor. The same or a second factor produced by these lymphocytes could at the same time exert a toxic effect on the glomerular basement membrane.

Key words

Nephrotic syndrome Immunological system Disorder of T cell function Suppressor T-cell 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Baker, P. J., Stashak, P. W., Amsbauch, D. F., Prescott, B., Barth, R. F.: Evidence for the existence of two functionally distinct types of cells which regular the antibody response to type II pneumococcal polysaccharide. J. Immunol. 105, 1581 (1970)Google Scholar
  2. 2.
    Barthold, D. R., Prescott, B., Stashak, P. W., Amsbauch, D. F., Baker, P. J.: Regulation of the antibody response to type III pneumococcal polysaccharide. III. Role of regulatory T cells in the development of an IgG and IgA antibody response. J. Immunol. 112, 1042 (1974)Google Scholar
  3. 3.
    Barrat, T. M., Soothill, J. F.: Controlled trial of cyclophosphamide in steroid-sensitive relapsing nephrotic syndrome of childhood. Lancet 1970 II, 479Google Scholar
  4. 4.
    Böyum, A.: Separation of leukocytes from blood and bone marrow. Introduction. Scand. J. Clin. Lab. Invest. 21 (suppl. 97), 51 (1968)Google Scholar
  5. 5.
    Caffey, J., Sibey, R.: Regrowth and overgrowth of the thymus after atrophy induced by the oral administration of adrenocorticosteroide to human infants. Pediatrics 26, 762 (1960)Google Scholar
  6. 6.
    Cameron, J. S.: Bright's disease today: The pathogenesis and treatment of glomerulonephritis. I. Brit. Med. J. 4, 87 (1972)Google Scholar
  7. 7.
    Folch, H., Waksman, B. H.: The splenic suppressor cell. II. Suppression of mixed lymphocyte reaction by thymus-dependent adherent cells. J. Immunol. 113, 140 (1974)Google Scholar
  8. 8.
    Habib, R., Kleinknecht, C.: The primary nephrotic syndrome of childhood. Classification and clinopathologic study of 406 cases. C. Path. A. 6, 417 (1971)Google Scholar
  9. 9.
    Heyman, W., Makker, S. P., Post, R. S.: The preponderance of males in the idiopathic nephrotic syndrome of childhood. Pediatrics 50, 814 (1972)Google Scholar
  10. 10.
    Hoyer, J. R., Raij, L., Vernier, R. L., Simmons, R. L., Najarian, J. S., Michael, A. F.: Recurrence of idiopathic nephrotic syndrome after renal transplantation. Lancet 1972 II, 343Google Scholar
  11. 11.
    Janeway, C. A., Moll, G. H., Armstrong, S. H., Jr., Wallace, W. M., Hallman, N., Barness, L. A.: Diuresis in children with nephrosis. Comparison of response to injection of normal human serum albumin and to infection, particularly measles. Trans. Ass. Am. Physns. 61, 108 (1948)Google Scholar
  12. 12.
    Kappler, J. W., Hunter, P. C., Jacobs, D., Lord, E.: Functional heterogeneity among the T-derived lymphocytes of the mouse. I. Analysis by adult thymectomy. J. Immunol. 113, 27 (1974)Google Scholar
  13. 13.
    Kumar, V., Caruso, T., Bennet, M.: Mechanisms of genetic resistance to Friend virus leukemia. III. Susceptibility of mitogen-responsive lymphocytes mediated by T cells. J. Exp. Med. 143, 728 (1976)Google Scholar
  14. 14.
    Michael, A. F., McLean, R. H., Roy, L. P., Westberg, N. G., Hoyer, J. R., Fish, A. J., Vernier, R. L.: Immunologic aspects of nephrotic syndrome. Kidney Int. 3, 105 (1973)Google Scholar
  15. 15.
    Movat, H. Z., Steiner, J. W., Slater, R. J.: The fine structure of the glomerulus in Bright's disease: A clinopathological study. In: Ciba Foundation Symposion on renal biopsy, p. 1 (eds. G. E. W. Wolstenholme and M. P. Cameron). London: Churchill Ltd. 1961Google Scholar
  16. 16.
    Rich, R. R., Rich, S. S.: Biological expression of lymphocyte activation. IV. Concanavalin A activated suppressor cells in mouse mixed lymphocyte reactions. J. Immunol. 114, 1112 (1975)Google Scholar
  17. 17.
    Schulte-Wissermann, H., Lemmel, E. M., Reitz, M., Beck, J., Freudenberg, J., Straub, E.: Untersuchungen zur zellulären Reaktivität an Patienten mit nephrotischem Syndrom und Glomerulonephritis in verschiedenen Krankheitsstadien. Mschr. Kinderheilk. 123, 485 (1975)Google Scholar
  18. 18.
    Shalhoub, R. J.: Pathogenesis of lipoid nephrosis: a disorder of T-cell function. Lancet 1974 II, 556Google Scholar
  19. 19.
    Sherman, R. L., Susin, M., Weksler, M. E., Becker, E. L.: Lipoid nephrosis in Hodgkin's disease. Am. J. Med. 52, 669 (1969)Google Scholar
  20. 20.
    Shou, L., Schwartz, S. A., Good, R. A.: Suppressor cell activity after Concanavalin A treatment of lymphocytes from normal persons. J. Exp. Med. 143, 1100 (1976)Google Scholar
  21. 21.
    Smithwick, E. M., Berkovich, S.: In vitro suppression of the lymphocyte response to tuberculin by live measles virus. Proc. Soc. Exp. Biol. Med. 123, 276 (1966)Google Scholar
  22. 22.
    Taniguchi, M., Tada, T.: Dual regulatory role of the thymus in the maturation of immune response in the rabbit. J. Exp. Med. 139, 108 (1974)Google Scholar
  23. 23.
    Tatal, N.: Immunologic and viral factors in the pathogenesis of systemic lupus erythematosis. Arthritis Rheum. 13, 887 (1970)Google Scholar
  24. 24.
    Tatal, N., Steinberg, A. D., Jakobs, M. E., Chused, E. M., Gazdar, A. F.: Immune cell cooperation, viruses, and antibodies to nucleic acids in New Zealand mice. J. Exp. Med. 134 (suppl.), 52 (1971)Google Scholar
  25. 25.
    Twomey, J. J., Laughter, A. H., Farrow, S., Douglas, C. C.: Hodgkin's disease, an immunodepleting and immunosuppressive disorder. J. Clin. Invest. 56, 467 (1975)Google Scholar
  26. 26.
    White, R. G., Boyd, J. F.: The effect of measles on the thymus ond other lymphoid tissues. Clin. Exp. Immun. 13, 343 (1973)Google Scholar
  27. 27.
    Winkelstein, A.: Differential effects of immunosuppressants on lymphocyte function. J. Clin. Invest. 52, 2293 (1973)Google Scholar
  28. 28.
    Yu, D. T. Y., Clements, P. J., Paulus, H. E., Peter, J. B., Levy, J., Barnett, E. V.: Human lymphocyte subpopulations. Effect of corticosteroids. J. Clin. Invest. 53, 565 (1974)Google Scholar
  29. 29.
    Zorini, C. O., Neri, A., Comis, M., Mannella, E., Paciucci, P. A.: Influence of Hodgkin's serum on P.H.A. stimulation of normal lymphocytes. Lancet 1974 I, 745Google Scholar
  30. 30.
    Zweiman, B.: Effect of viable and non-viable measles virus on proliferating human lymphocytes. Arch. Allergy Appl. Immun. 43, 600 (1972)Google Scholar

Copyright information

© Springer-Verlag 1977

Authors and Affiliations

  • H. Schulte-Wissermann
    • 1
  • E.-M. Lemmel
    • 1
  • M. Reitz
    • 1
  • J. Beck
    • 1
  • E. Straub
    • 1
  1. 1.Department of Pediatrics and First Department of Internal MedicineJohann Gutenberg UniversityMainzFederal Republic of Germany

Personalised recommendations